Overview

A Study to Test the Safety, Tolerability, and Blood Levels of UCB0022 in Healthy Participants and Participants With Parkinson's Disease

Status:
Recruiting

Trial end date:
2022-05-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to evaluate the safety, tolerability, and pharmacokinetic (PK) of UCB0022 and food effect.

Phase:

Phase 1

Details

Lead Sponsor:

UCB Biopharma SRL